Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

When does Parkinson's disease begin?

Identifieur interne : 001F83 ( Main/Exploration ); précédent : 001F82; suivant : 001F84

When does Parkinson's disease begin?

Auteurs : Carles Gaig [Espagne] ; Eduardo Tolosa [Espagne]

Source :

RBID : ISTEX:1085C4707DDF6FEAE74E96742A69601C0CC569B1

Descripteurs français

English descriptors

Abstract

Pathological and neuroimaging studies have shown that in Parkinson's disease (PD) there is a “subclinical” or “premotor” period during which dopaminergic neurons in the substantia nigra (SN) degenerate but typical motor symptoms have not yet developed. Post‐mortem studies based on nigral cell counts and evaluating dopamine levels in the striata, and imaging studies assessing the nigrostriatal pathway in vivo, have estimated that this time period could last 3 to 6 years. In addition, emerging evidence indicates that the neuropathological process of PD does not start in the SN but more likely elsewhere in the nervous system: in the lower brainstem and the olfactory bulb, or even more distant from the SN, such as in the peripheral autonomic nervous system. Patients with PD frequently can present non‐motor symptoms, such as hyposmia or constipation, years before the development of classical motor signs. The physiopathology of these “premotor” symptoms, though still unclear, is currently thought to be related to early involvement by the pathological process underlying PD of non‐dopaminergic lower brainstem structures or autonomic plexuses. However, the answer to the question “when does PD start” remains uncertain. Here, we review clinical, pathological, and neuroimaging data related to the onset of the pathological process of PD, and propose that its onset is non‐motor and that non‐motor symptoms could begin in many instances 10 and 20 years before onset of motor symptoms. The variable course of the disorder once the motor symptoms develop, suggests that the start and progression of premotor PD is also highly variable andgiven the heterogeneous nature of PD, may differ depending on the cause/s of the syndrome. When and where the neuropathological process develops in PD remains uncertain. © 2009 Movement Disorder Society

Url:
DOI: 10.1002/mds.22672


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">When does Parkinson's disease begin?</title>
<author>
<name sortKey="Gaig, Carles" sort="Gaig, Carles" uniqKey="Gaig C" first="Carles" last="Gaig">Carles Gaig</name>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1085C4707DDF6FEAE74E96742A69601C0CC569B1</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22672</idno>
<idno type="url">https://api.istex.fr/document/1085C4707DDF6FEAE74E96742A69601C0CC569B1/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000135</idno>
<idno type="wicri:Area/Istex/Curation">000135</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B85</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Gaig C:when:does:parkinson</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19877243</idno>
<idno type="wicri:Area/PubMed/Corpus">001B13</idno>
<idno type="wicri:Area/PubMed/Curation">001B13</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A96</idno>
<idno type="wicri:Area/Ncbi/Merge">002870</idno>
<idno type="wicri:Area/Ncbi/Curation">002870</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002870</idno>
<idno type="wicri:Area/Main/Merge">002844</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0038129</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C78</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002041</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C55</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Gaig C:when:does:parkinson</idno>
<idno type="wicri:Area/Main/Merge">002D52</idno>
<idno type="wicri:Area/Main/Curation">001F83</idno>
<idno type="wicri:Area/Main/Exploration">001F83</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">When does Parkinson's disease begin?</title>
<author>
<name sortKey="Gaig, Carles" sort="Gaig, Carles" uniqKey="Gaig C" first="Carles" last="Gaig">Carles Gaig</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009">2009</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">S2</biblScope>
<biblScope unit="page" from="S656">S656</biblScope>
<biblScope unit="page" to="S664">S664</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1085C4707DDF6FEAE74E96742A69601C0CC569B1</idno>
<idno type="DOI">10.1002/mds.22672</idno>
<idno type="ArticleID">MDS22672</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anatomic pathology</term>
<term>Asymptomatic</term>
<term>Diagnostic Imaging</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Lewy Bodies (physiology)</term>
<term>Motor system disorder</term>
<term>Movement (physiology)</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Substantia Nigra (pathology)</term>
<term>neuroimaging</term>
<term>non‐motor symptoms</term>
<term>pathology</term>
<term>premotor phase</term>
<term>subclinical period</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Lewy Bodies</term>
<term>Movement</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Diagnostic Imaging</term>
<term>Disease Progression</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Anatomopathologie</term>
<term>Asymptomatique</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Trouble moteur</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Pathological and neuroimaging studies have shown that in Parkinson's disease (PD) there is a “subclinical” or “premotor” period during which dopaminergic neurons in the substantia nigra (SN) degenerate but typical motor symptoms have not yet developed. Post‐mortem studies based on nigral cell counts and evaluating dopamine levels in the striata, and imaging studies assessing the nigrostriatal pathway in vivo, have estimated that this time period could last 3 to 6 years. In addition, emerging evidence indicates that the neuropathological process of PD does not start in the SN but more likely elsewhere in the nervous system: in the lower brainstem and the olfactory bulb, or even more distant from the SN, such as in the peripheral autonomic nervous system. Patients with PD frequently can present non‐motor symptoms, such as hyposmia or constipation, years before the development of classical motor signs. The physiopathology of these “premotor” symptoms, though still unclear, is currently thought to be related to early involvement by the pathological process underlying PD of non‐dopaminergic lower brainstem structures or autonomic plexuses. However, the answer to the question “when does PD start” remains uncertain. Here, we review clinical, pathological, and neuroimaging data related to the onset of the pathological process of PD, and propose that its onset is non‐motor and that non‐motor symptoms could begin in many instances 10 and 20 years before onset of motor symptoms. The variable course of the disorder once the motor symptoms develop, suggests that the start and progression of premotor PD is also highly variable andgiven the heterogeneous nature of PD, may differ depending on the cause/s of the syndrome. When and where the neuropathological process develops in PD remains uncertain. © 2009 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Espagne</li>
</country>
<region>
<li>Catalogne</li>
</region>
<settlement>
<li>Barcelone</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<region name="Catalogne">
<name sortKey="Gaig, Carles" sort="Gaig, Carles" uniqKey="Gaig C" first="Carles" last="Gaig">Carles Gaig</name>
</region>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F83 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F83 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:1085C4707DDF6FEAE74E96742A69601C0CC569B1
   |texte=   When does Parkinson's disease begin?
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024